Observational study on the biology of COVID-19 in Saarland
CORONA in the Saarland
Universität des Saarlandes · NCT04837755
This study looks at how COVID-19 affects people in different ways, including those with long-term symptoms, to learn more about the disease and its progression.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 0 Years to 110 Years |
| Sex | All |
| Sponsor | Universität des Saarlandes (other) |
| Locations | 1 site (Homburg, Saarland) |
| Trial ID | NCT04837755 on ClinicalTrials.gov |
What this trial studies
The CORSAAR study is an observational, prospective investigation aimed at understanding the natural biology of COVID-19. It includes patients with various forms of COVID-19, including those experiencing long-COVID-19, and collects comprehensive medical histories, measurements, and biomarkers at baseline, during hospitalization, and after discharge. The study focuses on cytokine measurements to gain insights into the disease's progression and effects.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with any form of COVID-19, including those suffering from long-COVID-19.
Not a fit: Patients who do not have COVID-19 or long-COVID-19 will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of COVID-19 and inform better treatment strategies for patients.
How similar studies have performed: Other observational studies on COVID-19 have shown success in understanding the disease, making this approach relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: all form of COVID-19 including long-COVID-19 Exclusion Criteria: \-
Where this trial is running
Homburg, Saarland
- Saarland University — Homburg, Saarland, Germany (RECRUITING)
Study contacts
- Study coordinator: Robert Bals, MD PhD
- Email: robert.bals@uks.eu
- Phone: +4968411615051
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Covid19